tiprankstipranks
Starling Oncology Institute (STLN)
NASDAQ:STLN
US Market
STLN
Starling Oncology Institute
RESEARCH TOOLSreports
Want to see STLN full AI Analyst Report?

Starling Oncology Institute (STLN) Ratios

212 Followers

Starling Oncology Institute Ratios

STLN's free cash flow for Q2 2026 was $0.17. For the 2026 fiscal year, STLN's free cash flow was decreased by $ and operating cash flow was $-0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.36 1.59 2.15 4.12 4.39
Quick Ratio
 1.15 1.35 1.96 3.73 4.08
Cash Ratio
 0.43 0.47 0.95 0.96 0.47
Solvency Ratio
 -0.15 -0.30 -0.35 -0.51 0.03
Operating Cash Flow Ratio
 <0.01 -0.35 -0.51 -1.04 -2.08
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -74.16M$ -67.63M$ -56.71M$ -8.72M$ -8.07M
Leverage Ratios
Debt-to-Assets Ratio
 0.59 0.63 0.71 0.57 0.41
Debt-to-Equity Ratio
 -4.19 -6.60 34.31 2.10 0.88
Debt-to-Capital Ratio
 1.31 1.18 0.97 0.68 0.47
Long-Term Debt-to-Capital Ratio
 1.45 1.25 0.96 0.60 0.40
Financial Leverage Ratio
 -7.15 -10.47 48.12 3.67 2.12
Debt Service Coverage Ratio
 -2.86 -3.76 -6.79 -8.00 -16.50
Interest Coverage Ratio
 -3.42 -3.20 -8.02 -11.36 -20.08
Debt to Market Cap
 0.13 0.14 4.02 0.58 0.67
Interest Debt Per Share
 1.09 1.24 1.74 1.71 1.54
Net Debt to EBITDA
 -2.90 -1.65 -1.44 -1.59 -1.39
Profitability Margins
Gross Profit Margin
15.69%15.20%13.73%18.37%20.63%
EBIT Margin
-4.88%-9.84%-14.53%-18.55%-28.52%
EBITDA Margin
-3.72%-8.46%-12.93%-16.74%-26.77%
Operating Profit Margin
-4.44%-7.18%-15.28%-23.75%-32.46%
Pretax Profit Margin
-6.18%-12.08%-16.44%-25.63%-0.04%
Net Profit Margin
-6.18%-12.06%-16.44%-25.62%0.06%
Continuous Operations Profit Margin
-6.18%-12.06%-16.44%-25.62%0.06%
Net Income Per EBT
100.00%99.78%100.00%99.96%-167.03%
EBT Per EBIT
139.11%168.33%107.56%107.90%0.11%
Return on Assets (ROA)
-20.36%-36.81%-37.44%-39.70%0.06%
Return on Equity (ROE)
209.81%385.53%-1801.70%-145.67%0.12%
Return on Capital Employed (ROCE)
-31.32%-38.51%-49.89%-44.15%-35.33%
Return on Invested Capital (ROIC)
-28.82%-35.70%-47.23%-42.58%57.65%
Return on Tangible Assets
-22.48%-41.39%-42.91%-45.12%0.07%
Earnings Yield
-5.53%-11.31%-278.86%-55.21%0.13%
Efficiency Ratios
Receivables Turnover
 8.80 8.47 8.08 7.56 6.24
Payables Turnover
 8.21 9.88 13.95 18.34 21.38
Inventory Turnover
 24.74 25.26 33.81 19.35 21.64
Fixed Asset Turnover
 18.48 15.21 10.44 8.10 7.64
Asset Turnover
 3.29 3.05 2.28 1.55 0.96
Working Capital Turnover Ratio
 16.41 0.00 4.66 3.10 2.24
Cash Conversion Cycle
 11.77 20.56 29.80 47.27 58.25
Days of Sales Outstanding
 41.46 43.07 45.17 48.31 58.45
Days of Inventory Outstanding
 14.75 14.45 10.80 18.86 16.87
Days of Payables Outstanding
 44.44 36.96 26.16 19.90 17.07
Operating Cycle
 56.22 57.52 55.96 67.17 75.32
Cash Flow Ratios
Operating Cash Flow Per Share
 <0.01 -0.27 -0.35 -0.49 -0.85
Free Cash Flow Per Share
 -0.03 -0.30 -0.40 -0.55 -0.92
CapEx Per Share
 0.04 0.03 0.05 0.06 0.08
Free Cash Flow to Operating Cash Flow
 -10.02 1.13 1.14 1.13 1.09
Dividend Paid and CapEx Coverage Ratio
 0.09 -7.68 -7.00 -7.95 -11.17
Capital Expenditure Coverage Ratio
 0.09 -7.68 -7.00 -7.95 -11.17
Operating Cash Flow Coverage Ratio
 <0.01 -0.24 -0.22 -0.30 -0.57
Operating Cash Flow to Sales Ratio
 <0.01 -0.05 -0.07 -0.11 -0.24
Free Cash Flow Yield
-0.52%-5.19%-130.78%-27.17%-56.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -21.23 -10.74 -0.44 -1.81 790.19
Price-to-Sales (P/S) Ratio
 1.08 1.07 0.06 0.46 0.48
Price-to-Book (P/B) Ratio
 -26.34 -34.09 6.46 2.64 0.98
Price-to-Free Cash Flow (P/FCF) Ratio
 -193.82 -19.28 -0.76 -3.68 -1.79
Price-to-Operating Cash Flow Ratio
 2.00K -21.79 -0.87 -4.14 -1.94
Price-to-Earnings Growth (PEG) Ratio
 0.32 0.00 0.02 <0.01 -7.86
Price-to-Fair Value
 -26.34 -34.09 6.46 2.64 0.98
Enterprise Value Multiple
 -32.04 -14.25 -1.90 -4.36 -3.17
Enterprise Value
 700.27M 605.98M 96.67M 236.63M 214.28M
EV to EBITDA
 -32.04 -14.25 -1.90 -4.36 -3.17
EV to Sales
 1.19 1.21 0.25 0.73 0.85
EV to Free Cash Flow
 -213.11 -21.81 -3.19 -5.79 -3.18
EV to Operating Cash Flow
 2.13K -24.65 -3.64 -6.52 -3.47
Tangible Book Value Per Share
 -0.41 -0.37 -0.25 0.43 1.15
Shareholders’ Equity Per Share
 -0.24 -0.17 0.05 0.77 1.69
Tax and Other Ratios
Effective Tax Rate
 0.00 <0.01 0.00 <0.01 2.67
Revenue Per Share
 5.70 5.44 5.24 4.40 3.47
Net Income Per Share
 -0.35 -0.66 -0.86 -1.13 <0.01
Tax Burden
 1.00 1.00 1.00 1.00 -1.67
Interest Burden
 1.27 1.23 1.13 1.38 <0.01
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.19 0.21 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.03 0.05 0.11
Income Quality
 >-0.01 0.41 0.50 0.44 -406.29
Currency in USD